Herpes through generations {#cesec10}
==========================

Women with previous herpes simplex virus type-1 (HSV-1) infection have persistent antibodies against the virus and can pass protection to their unborn babies. In laboratory studies using autopsied human tissue, the researchers showed that the antibodies remain in the trigeminal ganglion (a key site of HSV infection) in mothers and that they travel to the same site in their fetus. In studies in mice, they showed that these vertically transmitted antibodies completely protect newborn mice from infection. The findings suggest that [immunising women against HSV and similar infections could prevent serious brain disease in newborn babies](http://dx.doi.org/10.1128/mBio.00678-17){#interrefs10}.

Anti-coronavirus compound {#cesec20}
=========================

A new antiviral compound inhibits a range of coronaviruses including those that cause severe acute respiratory syndrome and Middle East respiratory syndrome. At present, there is no effective [antiviral drug against any known coronavirus](http://dx.doi.org/10.1126/scitranslmed.aal3653){#interrefs20}. The researchers screened potential compounds and identified GS-5734, a nucleoside analogue in clinical development for use against Ebola virus, as being active against human and animal coronaviruses in cultures of human airway epithelial cells. In mouse models, they showed that both prophylactic and early therapeutic treatment with the compound reduced viral load and improved respiratory function. The researchers will use the compound to continue to probe coronavirus biology and look for new treatment targets.

Speedy sepsis detection {#cesec30}
=======================

A [new portable, point-of-care device can detect markers of sepsis infection](http://dx.doi.org/10.1038/NCOMMS15949){#interrefs30} in a single drop of blood. Sepsis is a life-threatening problem that affects about 20% of patients in intensive care units (ICUs). This deadly immune reaction to infection is difficult to predict, and current blood-culture detection methods can take days. The new device measures total white blood cell count, neutrophil count, and CD64, a protein marker on the surface of neutrophils, the numbers of which surge with a patient\'s immune response. The researchers assessed the device in blood samples from 68 patients in ICUs in the USA: it correlated well with traditional tests and measuring of vital signs. The next step is to work out how the device can detect potential sepsis earlier and give a prognosis.

A difficile problem {#cesec40}
===================

The most difficult cases of *Clostridium difficile* infection---multiple recurring *C difficile* [infections---are becoming more common in the USA](http://dx.doi.org/10.7326/M16-2733){#interrefs40}. Findings from an analysis of a nationwide health insurance database show an increase in the annual incidence of multiple recurring *C difficile* infections of almost 190% between 2001 and 2012 (from 0·0107 to 0·0309 cases). The incidence of ordinary *C difficile* infections increased by about 40% in the same period. What has driven the increase is unknown, although wider use of broad-spectrum antibiotics and new bacterial strains might have contributed. The researchers stress the need to thoroughly assess new treatments for such infections such as faecal microbiota transplantation to ease the increasing burden on the health system.

The drugs do work {#cesec50}
=================

Two common antimicrobials can help patients recover from meticillin-resistant *Staphylococcus aureus* (MRSA) [skin abscesses](http://dx.doi.org/10.1056/NEJMoa1607033){#interrefs50}, and can thus prevent more serious consequential infections in other parts of the body. In a study done in hospitals across the USA, nearly 800 patients with uncomplicated skin abscesses were randomly assigned to one of three 10-day treatments: clindamycin (82% cure rate), co-trimoxazole (trimethoprim-sulfamethoxazole; 85%), or placebo (63%). The findings disprove the common assumption that antimicrobial treatment is little better than doing nothing for such skin infections.

Dam schistosomiasis {#cesec60}
===================

[The Three Gorges Dam](http://dx.doi.org/10.1371/journal.pntd.0005661){#interrefs60} in the Yangtze river in central China is the world\'s largest power station, becoming operational in 2012. Since then, the dam\'s downstream ecological impact has affected the distribution of fresh water snails that carry schistosoma parasites according to findings from a new study. The study showed that annual runoff into Dongting lake, where the prevalence of schistosomiasis is among the highest in China, decreased by 21%: the density of living snails in turn decreased by 94% and the number of human infections dropped by 87% between 2003 and 2015.

Disease truncated {#cesec70}
=================

[Mass drug administration](https://doi.org/10.1371/journal.pntd.0005633){#interrefs70} is successfully curbing the rates of lymphatic filariasis, known as elephantiasis, in Cameroon. Mass administration of the antiparasitic drugs ivermectin and albendazole began in 2008, prompted by a drive from WHO, which aims to eliminate the disease by 2020. Cameroonian researchers studied more than 5000 children in five health districts in the country where drug coverage was at least 65%: they detected only 21 cases of the disease, which is below the WHO threshold for stopping mass drug administration. The researchers urge the need for surveillance activities to assess whether the prevalence might increase if treatment is stopped.
